Change in echocardiography in patients with transthyretin amyloid cardiomyopathy with tafamidis treatment

被引：0
|
作者：
Morioka, M. [1 ]
Takashio, S. [1 ]
Fujiyama, H. [1 ]
Oike, F. [1 ]
Hanatani, S. [1 ]
Usuku, H. [1 ]
Yamamoto, E. [1 ]
Matsushita, K. [1 ]
Tsujita, K. [1 ]
机构：
[1] Kumamoto Univ Hosp, Kumamoto, Japan
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1764 / 1764
页数：1
相关论文
共 50 条
  • [31] Comparison of Transthyretin Amyloid Cardiomyopathy Patients Taking Tafamidis and Those Not Taking Tafamidis Using Two-Dimensional Speckle Tracking Echocardiography
    Oike, Fumi
    Usuku, Hiroki
    Egashira, Kouichi
    Komorita, Takashi
    Fujisue, Koichiro
    Sueta, Daisuke
    Takashio, Seiji
    Yamamoto, Eiichiro
    Tsujita, Kenichi
    CIRCULATION, 2022, 146
  • [32] Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)
    Hanna, Mazen
    Damy, Thibaud
    Grogan, Martha
    Stewart, Michelle
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Maurer, Mathew S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 141 : 98 - 105
  • [33] Effect of tafamidis on left atrial function in patients with transthyretin amyloid cardiomyopathy
    Uemura, K.
    Ichikawa, Y.
    Nagai, S.
    Takeuchi, M.
    Nishihara, Y.
    Takeuchi, K.
    Oota, E.
    Odajima, S.
    Kintsu, M.
    Todo, S.
    Fukuda, T.
    Hisamatsu, E.
    Hirata, K.
    Tanaka, H.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [34] Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
    Elliott, Perry
    Drachman, Brian M.
    Gottlieb, Stephen S.
    Hoffman, James E.
    Hummel, Scott L.
    Lenihan, Daniel J.
    Ebede, Ben
    Gundapaneni, Balarama
    Li, Benjamin
    Sultan, Marla B.
    Shah, Sanjiv J.
    CIRCULATION-HEART FAILURE, 2022, 15 (01) : E008193
  • [35] Five-year Survival With Tafamidis In Patients With Transthyretin Amyloid Cardiomyopathy
    Hoffman, James E.
    Gundapaneni, Balarama
    Sultan, Marla B.
    Elliott, Perry
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S102 - S102
  • [36] Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy
    Damy, T.
    Elliott, P.
    Gundapaneni, B.
    Tai, S. See
    Sultan, M. B.
    Drachman, B. M.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2142 - 2142
  • [37] Tafamidis prevents deterioration of physical performance in patients with transthyretin amyloid cardiomyopathy
    Eslam, R. Badr
    Capelle, C.
    Rettl, R.
    Dachs, T.
    Binder, C.
    Ligios, L. Camuz
    Duca, F.
    Alasti, F.
    Wolzt, M.
    Bonderman, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 399 - 399
  • [38] Tafamidis Free Acid 61 Mg in Patients With Transthyretin Amyloid Cardiomyopathy
    Nativi-Nicolau, Jose
    van der Meer, Peter
    Gundapaneni, Balarama
    Sultan, Marla B.
    Garcia-Pavia, Pablo
    CIRCULATION, 2020, 142
  • [39] Tafamidis medication adherence and persistence in patients with transthyretin amyloid cardiomyopathy in Japan
    Kato, Takao
    Ines, Monica
    Minamisawa, Masatoshi
    Benjumea, Darrin
    Keohane, Denis
    Alvir, Jose
    Kim, Ruth
    Chen, Yong
    Peixoto, Telma
    Kent, Matthew
    Wogen, Jenifer
    Ishii, Tomonori
    Crowley, Aaron
    Sugino, Toshiya
    Izumiya, Yasuhiro
    ESC HEART FAILURE, 2024, 11 (05): : 2481 - +
  • [40] Effect of tafamidis on left atrial function of patients with transthyretin amyloid cardiomyopathy
    Uemura, Koya
    Ichikawa, Yasushi
    Nagai, Shun
    Nishihara, Yu
    Todo, Saki
    Oota, Eri
    Odajima, Susumu
    Takeuchi, Kimikazu
    Kintsu, Masayuki
    Fukuda, Terunobu
    Hisamatsu, Eriko
    Hirata, Ken-ichi
    Tanaka, Hidekazu
    HEART AND VESSELS, 2024, 39 (09) : 810 - 817
12345